​Cell therapy involves expanding or engineering cells to favorably impact the course of diseases. GMP cell therapy consumables include media, reagents, serum, containers, and equipment required to produce cell therapies under cGMP guidelines. They ensure product quality and safety.

Global GMP cell therapy consumables market is estimated to be valued at USD 14.04 Mn in 2024 and is expected to reach USD 80.03 Mn by 2031, exhibiting a compound annual growth rate (CAGR) of 28.3% from 2024 to 2031.

Key Takeaways

Key players operating in the GMP cell therapy consumables market are Thermo Fisher Scientific Inc., Lonza Group, Merck KGaA, Corning Inc., Sartorius AG, Danaher Corporation, Miltenyi Biotec, Stemcell Technologies Inc., GE Healthcare.

The GMP Cell Therapy Consumables Market Demand is expected to witness lucrative opportunities due to the rising adoption of cell therapies in disease treatment. Initiatives by market players to develop advanced culture media and innovative containers are also fueling market growth.

Technological advancements such as continuous manufacturing platforms, automated monitoring systems, and single-use bioreactors are minimizing production costs and improving process efficiency in cell therapy manufacturing.

Market Drivers

The growing pipeline of cell therapy candidates is a key factor driving the demand for GMP cell therapy consumables. As of 2022, the FDA has approved over 30 cell therapies. The increasing funding in cell therapy research is also propelling market expansion. Advanced technologies that facilitate automated, closed, and scalable manufacturing further encourage market players to introduce innovative consumables. Regulatory approvals of advanced therapies and growing awareness about their therapeutic benefits in cancer and other diseases will continue bolstering market growth over the forecast period.

Current challenges in GMP Cell Therapy Consumables Market:

There are several challenges being faced by the GMP cell therapy consumables market. Firstly, the high costs associated with compliance to stringent regulatory standards and certifications is a major challenge. Secondly, the lack of skilled professionals needed to manufacture cell therapy products under GMP standards poses operational challenges. Thirdly, the lengthy and complex approval process for new cell therapy products acts as a bottleneck in commercialization. Lastly, the limited medical reimbursements available for new cell therapies in various countries restricts their uptake.

SWOT Analysis

Strength: High demand for cell therapy products to treat conditions like cancer and genetic disorders. Growing R&D investments from biotech and pharma companies into cell therapies.

Weakness: Heavy reliance of end-users on vendors increases pricing pressures. Risk of contamination from raw materials poses safety concerns.

Opportunity: Emergence of novel technologies like gene editing and artificial intelligence offers new avenues. Increasing collaborations between industry and academic institutes to advance research.

Threats: Stringent regulatory framework delays product approvals. Ethical issues around the use of stem cells limits social acceptance.

In terms of value, the North America region accounted for the major share in the GMP cell therapy consumables market in 2024 due to significant research funding and presence of major developers. Europe also held substantial market share owing to rising demand for cell therapy products across Germany, France and U.K.

The Asia Pacific GMP Cell Therapy Consumables Market Regional Analysis is expected to witness the fastest growth during the forecast period from 2024 to 2031. This can be attributed to growing R&D investments by pharmaceutical firms, increasing diagnosis rates, and rising medical tourism in countries like China, India and Japan.

Get More Insights on- GMP Cell Therapy Consumables Market

Discover the Report for More Insights, Tailored to Your Language:

• French
• German
• Italian
• Russian
• Japanese
• Chinese
• Korean
• Portuguese

About Author:

Priya Pandey is a dynamic and passionate editor with over three years of expertise in content editing and proofreading. Holding a bachelor's degree in biotechnology, Priya has a knack for making the content engaging. Her diverse portfolio includes editing documents across different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. Priya's meticulous attention to detail and commitment to excellence make her an invaluable asset in the world of content creation and refinement.
(LinkedIn- https://www.linkedin.com/in/priya-pandey-8417a8173/)